Brimonidine–montmorillonite hybrid formulation for topical drug delivery to the eye-Reference-Cited by-同舟云学术

Brimonidine–montmorillonite hybrid formulation for topical drug delivery to the eye

Published:2020 Issue:35 Volume:8 Page:7914-7920
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Park Chun Gwon¹²³⁴⁵,Choi Goeun⁶⁷⁸⁹⁵,Kim Myung Hun¹⁰¹¹¹²⁵,Kim Se-Na¹³¹⁴¹¹¹²⁵,Lee Hanna⁶⁷⁸⁹⁵,Lee Na Kyeong¹²³⁴⁵,Choy Young Bin¹⁰¹¹¹²⁵¹³^ORCID,Choy Jin-Ho⁶⁷⁸⁹⁵^ORCID

Affiliation:

1. Department of Biomedical Engineering

2. SKKU Institute for Convergence

3. Sungkyunkwan University (SKKU)

4. Suwon

5. Republic of Korea

6. Intelligent Nanohybrid Materials Laboratory (INML)

7. Institute of Tissue Regeneration Engineering (ITREN)

8. Dankook University

9. Cheonan 31116

10. Interdisciplinary Program in Bioengineering, College of Engineering

11. Seoul National University

12. Seoul

13. Institute of Medical & Biological Engineering

14. Medical Research Center

Abstract

Ternary hybrids of brimonidine, montmorillonite and polyvinyl alcohol (BMD-MMT@PVA) can improve ocular drug bioavailability when administered topically to the eye.

Funder

Korea Health Industry Development Institute

National Research Foundation of Korea

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2020/TB/D0TB01213K

Reference55 articles.

1. Newer Therapeutic Vistas for Antiglaucoma Medicines

2. Foreword